6533b836fe1ef96bd12a075c

RESEARCH PRODUCT

Plasma cytokine profiles in patients with celiac disease and selective IgA deficiency

Corazza Gino RobertoDomenico LioVincenzo MarinoLetizia ScolaFrancesco CataldoCrivello A

subject

business.industrymedicine.medical_treatmentImmunologyDiseasePlasma levelsSelective IgA deficiencymedicine.diseaseCoeliac diseaseCytokineImmunopathologyPediatrics Perinatology and Child HealthImmunologyBlood plasmamedicineImmunology and AllergyIn patientbusiness

description

Celiac disease (CD) and selective IgA deficiency (IgAD) are frequently associated, and share the same genetic background. The aim of the present study was to evaluate both Type 1 and 2 plasma cytokine levels in CD and in CD-IgAD. IL-2, TNF-alpha, IL-10, IL-4 and IL-13 plasma levels were measured both at diagnosis and after a gluten-free diet (GFD) in 32 CD patients, in 27 CD-IgAD patients and in 30 healthy controls. IFN-gamma levels were significantly higher in CD and CD-IgAD than in controls, TNF-alpha displayed significantly higher levels in CD-IgAD when compared both with controls and with CD, and IL-2 was in CD-IgAD significantly increased respect to controls. Kinetics of the Type 1 cytokine plasma levels did not show a clear relationship with the GFD in both groups of CD patients, and particularly in those with IgAD. IL-4 and IL-13, both at diagnosis and after a GFD, were not significantly different in controls and in celiac patients (with and without IgAD). IL-10, whose production is stimulated by the TNF-alpha, had significantly higher plasma levels in CD-IgAD, but not in CD patients, with a significant decrease after a GFD. CD and especially CD-IgAD patients display persistently higher pro-inflammatory cytokine levels, suggesting a persistent state of activation of pro-phlogistic signals in CD, particularly when IgAD coexists. Serial measurement of serum IL-10 may be an adjunctive evaluating criterion in the follow-up of CD-IgAD patients.

https://doi.org/10.1034/j.1399-3038.2003.00053.x